DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Lucentis (Ranibizumab) - Current Clinical Trials

 
 



Lucentis Related Clinical Trials

Study To Determine Safety/Efficacy of Lucentis For Treatment Of Retinal Angiomatous Proliferation Secondary To Age Related Macular Degeneration [Completed]

Safety Study of PF582 Versus Lucentis in Patients With Age Related Macular Degeneration [Active, not recruiting]

Effect of Intravitreal Ranibizumab on Radiation Retinopathy Following Plaque Brachytherapy for Choroidal Melanoma [Completed]

Ranibizumab (Lucentis) for Polypoidal Choroidal Vasculopathy [Completed]

Ranibizumab for the Inhibition of Neovascularization in Pterygia [Completed]

Safety and Efficacy Study of BCD-021 Compared to Lucentis® in Patients With Neovascular Wet Age-related Macular Degeneration [Not yet recruiting]

Efficacy Study of Lucentis in the Treatment of Retinoblastoma [Recruiting]

Combination Lucentis and Ocular Photodynamic Therapy With Visudyne, With Evaluation-based Retreatment [Completed]

Efficacy Study of Lucentis in the Treatment of Diabetic Macular Edema [Completed]

Safety Study of 2.0mg Lucentis to Treat Polypoidal Choroidal Vasculopathy [Active, not recruiting]

20089 TA+Lucentis Combo Intravitreal Injections for Treatment of Neovascular Age-related Macular Degeneration (AMD) [Completed]

Lucentis Versus Mitomycin C During Glaucoma Surgery [Completed]

Ranibizumab for Neurofibromas Associated With Neurofibromatosis 1 [Active, not recruiting]

Ranibizumab for the Inhibition of Neovascularization in the Cornea Following Corneal Transplant Surgery [Completed]

Lucentis for Age-related Macular Degeneration Pigment Epithelial Detachments [Completed]

Intravitreal Ranibizumab for the Treatment of Choroidal Neovascularization in Ocular Histoplasmosis Syndrome [Recruiting]

Development of Intravitreal Ranibizumab by Determining the Pathogenesis of Macular Edema With Retinal Vein Occlusion [Recruiting]

Evaluation of Changes in the Parameters of Optical Coherence Tomography After Intravitreal Injection of Lucentis [Not yet recruiting]

Efficacy of Ranibizumab in Combination With Photodynamic Therapy for Wet Age-Related Macular Degeneration [Not yet recruiting]

A Study of Ranibizumab Administered Monthly or on an As-needed Basis in Patients With Subfoveal Neovascular Age-related Macular Degeneration (HARBOR) [Completed]

Ranibizumab and the Risk of Arterial Thromboembolic Events [Terminated]

Lucentis as an Adjuvant Therapy With TTT-ICG Based in Choroidal Melanoma [Completed]

The LIMO Study, Lucentis for Treatment of Uveitic Patients With Refractory Cystoid Macular Oedema [Recruiting]

Efficacy and Safety of Lucentis® (Ranibizumab Intravitreal Injections) in Chilean Patients With Diabetic Macular Edema. [Not yet recruiting]

Study EvAluating Genotypes While Using Lucentis 2 [Completed]

Pilot Study Reduced Fluence PDT /Visudyne With Ranibizumab vs Ranibizumab Monotherapy for Exudative Age-related Macular Degeneration (AMD) [Withdrawn]

Laser-Ranibizumab-Triamcinolone for Diabetic Macular Edema [Completed]

Pilot Study of Lucentis Combined With Proton Beam Irradiation in Treating Wet Age-related Macular Degeneration [Completed]

Ozurdex With Rescue Lucentis for Treating Macular Edema Secondary to Retinal Vein Occlusion [Recruiting]

Microperimetry and Optical Coherence Tomography (OCT) With Lucentis for Diabetic Macular Edema (DME) [Active, not recruiting]

A Phase 3 Safety and Efficacy Study of Fovista® (E10030) Intravitreous Administration in Combination With Lucentis® Compared to Lucentis® Monotherapy [Recruiting]

A Phase 3 Safety and Efficacy Study of Fovista® (E10030) Intravitreous Administration in Combination With Lucentis® Compared to Lucentis® Monotherapy [Active, not recruiting]

Efficacy/Safety of Verteporfin Photodynamic Therapy and Ranibizumab Compared With Ranibizumab in Patients With Subfoveal Choroidal Neovascularization [Completed]

French Evaluation Group Avastin Versus Lucentis [Completed]

A Study of the Efficacy and Safety of Ranibizumab Injection in Patients With Macular Edema Secondary to Branch Retinal Vein Occlusion (BRAVO) [Completed]

A Study of the Efficacy and Safety of Ranibizumab Injection in Patients With Macular Edema Secondary to Central Retinal Vein Occlusion (CRUISE) [Completed]

Intravitreal Ranibizumab for Vitreous Hemorrhage Due to Proliferative Diabetic Retinopathy (N) [Completed]

Comparison of Changes of Inflammatory Proteins in Aqueous Humour of Subjects Treated With Avastin vs Lucentis [Completed]

Frequent Dosing Regimen of Lucentis for Subjects With Persistent Diabetic Macular Edema Despite Standard antiVEGF Dosing [Withdrawn]

Study Comparing Ranibizumab Monotherapy With Combined Verteporfin Therapy in Subfoveal CNV [Completed]

Lucentis Utilizing Visudyne (LUV Trial) Combination Therapy in the Treatment of Age-Related Macular Degeneration [Terminated]

Study of 2.0 mg Ranibizumab in Subjects With Ischemic Central Retinal Vein Occlusion (RAVE2) [Terminated]

Change Oxygen Consumption Following Intravitreal Treatment of Lucentis (Ranibizumab) in Eyes With Diabetic Macular Edema [Not yet recruiting]

Ranibizumab Intravitreal Injections Versus Sham Control in Patients With Branch Retinal Vein Occlusion (BRVO) [Recruiting]

Ranibizumab for Edema of the Macula in Diabetes: Protocol 3 With High Dose - the READ 3 Study [Recruiting]

Ranibizumab Intravitreal Injections Versus Sham Control in Patients With Central Retinal Vein Occlusion (CRVO) [Recruiting]

Dosing Study of Ranibizumab for Diabetic Retinal and Macular Edema [Active, not recruiting]

OZURDEX in Age Related Macular Degeneration as Adjunct to Ranibizumab [Recruiting]

Ranibizumab for the Management of Recurrent Nosebleeds in Patients With Hereditary Hemorrhagic Telangiectasia (HHT) [Withdrawn]

Study to Investigate the Safety and Efficacy of Ranibizumab in Patients With Choroidal Neovascularisation Due to Causes Other Than Age Related Macular Degeneration [Completed]

25-G Vitrectomy With Ranibizumab or Triamcinolone Acetonide on PDR in China-Randomized Clinical Trial [Recruiting]

Sub-tenon Triamcinolone Acetonide in Age-Related Macular Degeneration as Adjunct to Ranibizumab [Recruiting]

A Study of Ranibizumab Injection in Subjects With Clinically Significant Macular Edema (ME) With Center Involvement Secondary to Diabetes Mellitus (RIDE) [Completed]

A Study of Ranibizumab Injection in Subjects With Clinically Significant Macular Edema (ME) With Center Involvement Secondary to Diabetes Mellitus (RISE) [Completed]

Impact of Lucentis on Psychological Morbidity in Patients With Retinal Vein Occlusion [Active, not recruiting]

Safety and Efficacy of Ranibizumab in Japanese Patients With Subfoveal Choroidal Neovascularization Secondary to Age-related Macular Degeneration [Completed]

Comparison of Pharmacokinetics of and Effect on Systemic VEGF Levels in Age Related Macular Degeneration Patients [Recruiting]

Laser-Ranibizumab-Triamcinolone for Proliferative Diabetic Retinopathy [Completed]

Ranibizumab for Macular Edema Secondary to Branch Retinal Vein Occlusion in Patients With Fair Vision [Recruiting]

Ranibizumab for Treating Submacular Vascularized Pigment Epithelial Detachments [Completed]

Reduced-fluence Verteporfin Photodynamic Therapy Plus Ranibizumab for Choroidal Neovascularization in Pathologic Myopia [Completed]

Retinal and Retinal Pigment Epithelium (RPE) Autoimmunity in Age-related Macular Degeneration (AMD) - Correlation With Lucentis(R) Therapy [Completed]

Efficacy and Safety of Ranibizumab in Patients With Visual Impairment Due to Choroidal Neovascularization Secondary to Pathologic Myopia [Completed]

Ranibizumab Versus Low-fluence Photodynamic Therapy in the Treatment of Chronic Central Serous Chorioretinopathy [Completed]

Ranibizumab in Diabetic Vitrectomy [Active, not recruiting]

LUCAS (Lucentis Compared to Avastin Study) [Completed]

Phase 2 Study of an Ocular Sirolimus (Rapamycin) Formulation in Combination With Lucentis® in Patients With Age-Related Macular Degeneration [Terminated]

Wet AMD Recurrence Rate in Patients Stable on Three Month Ranibizumab Dosing [Completed]

Ranibizumab as Adjuvant Therapy for the Treatment of Choroidal Melanoma (Cohort 2) [Completed]

Comparison of Age-related Macular Degeneration Treatments Trials: Lucentis-Avastin Trial [Active, not recruiting]

Efficacy and Safety of Verteporfin Added to Ranibizumab in the Treatment of Symptomatic Macular Polypoidal Choroidal Vasculopathy [Completed]

Lucentis to Treat Pigment Epithelial Detachment [Completed]

Safety & Efficacy Study Evaluating the Combination of Bevasiranib & Lucentis Therapy in Wet AMD (CARBON) [Withdrawn]

Safety and Efficacy of Intravitreal Ranibizumab as a Preoperative Adjunct Treatment Before Vitrectomy Surgery in Proliferative Diabetic Retinopathy (PDR) Compared to Vitrectomy Alone [Active, not recruiting]

Macular EpiRetinal Brachytherapy Versus Lucentis® Only Treatment (MERLOT) [Active, not recruiting]

Verteporfin Photodynamic Therapy Administered in Conjunction With Ranibizumab in Patients With Subfoveal Choroidal Neovascularization Secondary to Age-related Macular Degeneration (AMD) [Terminated]

Study of Treatment Effects of Combination Therapy of Lucentis Plus Reduced Fluence PDT With Visudyne in Patients With Exudative AMD [Recruiting]

Safety & Efficacy Study Evaluating the Combination of Bevasiranib & Lucentis Therapy in Wet AMD [Terminated]

Lucentis (Ranibizumab) in Diabetic Macular Oedema: a Treatment Evaluation [Completed]

Evaluation of Wet Age-Related Macular Degeneration (AMD) Genetic Profile Interactions With Ranibizumab Treatment Outcomes [Recruiting]

Posterior Vitreous Detachment (PVD) Assessment During Dual Retinal Vein Occlusion (RVO) Lucentis Evaluations [Not yet recruiting]

Intravitreal Ranibizumab to Treat Macular Edema After Panretinal Photocoagulation (Phase II) [Terminated]

Lucentis to Treat Retinopathy of Prematurity (ROP) 3 Plus Disease [Completed]

25-Gauge Vitrectomy With Ranibizumab or Triamcinolone Acetonide on Proliferative Diabetic Retinopathy in China [Recruiting]

An Extension Study to Evaluate Safety and Tolerability of Ranibizumab in Macular Edema Secondary to Retinal Vein Occlusion (Cohort 2) [Completed]

Panretinal Photocoagulation (PRP) Plus Ranibizumab for Proliferative Diabetic Retinopathy [Completed]

Bevacizumab Versus Ranibizumab for the Treatment of Diabetic Macular Edema [Active, not recruiting]

Study to Evaluate the Effects of Ranibizumab (Lucentis) for Patients With Rubeosis and Neovascular Glaucoma [Completed]

Bloodstream Absorption of Avastin and Lucentis After Injection Into the Eye [Completed]

Randomized Study for Efficacy and Safety of Ranibizumab 0.5mg in Treat-extend and Monthly Regimens in Patients With nAMD [Active, not recruiting]

Efficacy Study of Ranibizumab on Patients With Age-related Macular Degeneration. [Completed]

Lucentis for New Onset Neovascular Glaucoma [Withdrawn]

Efficacy and Safety of Ranibizumab 0.5 vs Veteporfin PDT in Patients With Visual Impairment Due to Choroidal Neovascularization Secondary to Pathologic Myopia [Recruiting]

Treatment of Exudative and Vasogenic Chorioretinal Diseases Including Variants of AMD and Other CNV Related Maculopathy [Completed]

Comparing the Effectiveness and Costs of Bevacizumab to Ranibizumab in Patients With Diabetic Macular Edema (BRDME) [Recruiting]

Lucentis for Central Retinal Vein Occlusion (CRVO) [Completed]

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2015